Obeticholic Acid

Catalog No.S7660 Synonyms: INT-747, 6-ECDCA

Obeticholic Acid Chemical Structure

Molecular Weight(MW): 420.63

Obeticholic Acid is a potent and selective farnesoid X receptor (FXR) agonist with EC50 of 99 nM. Phase 3.

Size Price Stock Quantity  
USD 97 In stock
USD 347 In stock
USD 977 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

3 Customer Reviews

  • HuCCT1 cells were treated with OCA (1 μM) and control solvent in the presence and absence of IL-6 (20 ng/mL). EMT-related proteins were examined by western blotting. β-actin was used as a control.

    Cell Physiol Biochem, 2018, 48(1):158-172. Obeticholic Acid purchased from Selleck.

    (D) Expression of hepatic FXR target genes, n = 3. Data are expressed as mean ± SD, ###P < 0.001 versus group 1, *P < 0.05, **P < 0.01, and ***P b 0.001 versus group 2, sP < 0.05, ssP < 0.01, and sssP < 0.001 versus group 3

    Toxicol Appl Pharmacol, 2017, 315:23-34. Obeticholic Acid purchased from Selleck.

  • (c) Functional bile canaliculi or lack thereof in PHHs within MPTCs (12 d of drug treatment) as visualized by transport of fluorescent (green) dye into the canaliculi between PHHs. DMSO-treated MPCC control image is shown to the far right. (d) Neutral lipid (Nile red, green) staining of PHHs within MPTCs (12 d of drug treatment). DMSO-treated MPCC control image is shown to the far right. (e) NR1I2 (PXR) gene expression in drug-treated MPTCs relative to DMSOtreated MPTC controls (12 d of treatment). (f) ABCC2 (MRP2) gene expression in drug-treated MPTCs relative to DMSO-treated MPTC controls (12 d of treatment). (g) IL-6 levels in drug-treated MPTC supernatants (6 d of treatment). In all panels, statistical significance is displayed relative to DMSO-treated MPTCs. *p r 0.05, **p r 0.01, ***p r 0.001, and ****p r 0.0001. Scale bars on images represent 80 mm.

    Integr Biol (Camb), 2017, 9(8):662-677. Obeticholic Acid purchased from Selleck.

Purity & Quality Control

Choose Selective FXR Inhibitors

Biological Activity

Description Obeticholic Acid is a potent and selective farnesoid X receptor (FXR) agonist with EC50 of 99 nM. Phase 3.
FXR [1]
99 nM(EC50)
In vitro

In HuH7 cells, Obeticholic Acid acts as a potent FXR agonist with EC50 of 85 nM. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells NXr2TIc3TnWwY4Tpc44h[XO|YYm= NVzqNW9uSWexbnnzeEBi[3Srdnn0fUBifCCIWGKg[ZhxemW|c3XkJIlvKEORU{GgZ4VtdHNiYomgZ4VtdC2kYYPl[EBjcW:udX3pcoV{[2WwY3WgZZN{[XluIFXDOVA:QTlibl2= MXKyNFAyPDh5MB?=
HeLa cells M1LzdmZ2dmO2aX;uJIF{e2G7 MXOyOEBp MlHMRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDmeYxtKGynbnf0bEBHYFJiZYjwdoV{e2WmIHnuJGhmVGFiY3XscJMh[2:2cnHud4Zm[3SnZDD3bZRpKHCVR{WtbJVu[W5iUmjSJIFnfGW{IEK0JIhzeyCkeTDEeYFtNUeubzDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4yPiEQvF2= M{XW[FI2QTN2MkK3
CHO cells NHHUN4VHfW6ldHnvckBie3OjeR?= NVzkfGFYPSCq MkHORYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDUS3I2KGW6cILld5Nm\CCrbjDDTG8h[2WubIOgZYZ1\XJiNTDodpMh[nliQ2LFMYRzcX[nbjDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE44PTVizszN M3m3bVE4Pjh3NkCz
NCI-H716 cells Ml;5SpVv[3Srb36gZZN{[Xl? NH22d3JC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHRIWjVicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJG5EUS2KN{G2JINmdGy|IHHzd4V{e2WmIHHzJIlvfHKjY3XscJVt[XJiY1HNVEBt\X[nbDDifUBVWi2IUlXUJIF{e2G7LDDFR|UxRTJyIN88US=> NHy0dnYzOTR3OUW4NC=>
mouse GLUTag cells MY\GeY5kfGmxbjDhd5NigQ>? MnvhRYdwdmm|dDDhZ5Rqfmm2eTDheEBIWC2EQWKxJIlvKG2xdYPlJGdNXVSjZzDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBqdnS{YXPlcIx2dGG{IHPBUXAhdGW4ZXy= M4XlUVI1Ozh5M{K1
human HepG2 cells NG[xeJpHfW6ldHnvckBie3OjeR?= M4fGdVExKM7:TR?= M2PCWVE5KGh? MoXjRYdwdmm|dDDhZ5Rqfmm2eTDheEBHYFJiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMhfXC{ZXf1cIF1cW:wIH;mJHNJWCCvUl7BJIV5eHKnc4Ppc44h[XRiMUCgeW0h[W[2ZYKgNVghcHK|IHL5JHJVNVCFUjDhcoFtgXOrcx?= M33Hb|I1Ozh5M{K1
mouse primary hepatocytes MW\GeY5kfGmxbjDhd5NigQ>? M{\rVGFod26rc4SgZYN1cX[rdImgZZQhTliUIHnuJI1wfXOnIIDybY1ienliaHXwZZRw[3m2ZYOgZZN{\XO|ZXSgZZMhfXC{ZXf1cIF1cW:wIH;mJGJGW1BibWLORUBmgHC{ZYPzbY9v MnrGNlQ{QDd|MkW=

... Click to View More Cell Line Experimental Data

In vivo In rat cholestasis model, Obeticholic Acid promotes bile flow, and protects hepatocytes against acute necrosis caused by LCA. [1] Obeticholic Acid (p.o.) improves proteinuria, ameliorates renal structural changes, and modulates renal inflammation and oxidative stress in WD-fed DBA mice. [2] In thioacetamide (TAA)-intoxicated and bile-duct-ligated (BDL) rats, Obeticholic Acid (30 mg/kg p.o.) reactivates the FXR downstream signaling pathway and decreases portal pressure by lowering total IHVR without deleterious systemic hypotension. [3]


Animal Research:


+ Expand
  • Animal Models: Rat cholestasis model
  • Formulation: 7 μmol/kg/min
  • Dosages: Saline
  • Administration: Infused at the right jugular vein using PE-50 polyethylene tubing
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 84 mg/mL (199.7 mM)
Ethanol 84 mg/mL warmed (199.7 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 420.63


CAS No. 459789-99-2
Storage powder
in solvent
Synonyms INT-747, 6-ECDCA

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03633227 Recruiting Liver Cirrhosis Biliary Intercept Pharmaceuticals June 22 2018 Phase 4
NCT03439254 Recruiting Compensated Cirrhosis|Nonalcoholic Steatohepatitis Intercept Pharmaceuticals August 30 2017 Phase 3
NCT02430077 Recruiting Familial Partial Lipodystrophy University of Texas Southwestern Medical Center June 2016 Phase 2
NCT03253276 Recruiting Primary Biliary Cirrhosis University of Aarhus May 19 2016 Early Phase 1
NCT02654236 Recruiting Alcohol Consumption Suthat Liangpunsakul|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Intercept Pharmaceuticals|Indiana University April 2016 Not Applicable
NCT02633956 Completed Nonalcoholic Steatohepatitis Intercept Pharmaceuticals December 4 2015 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    What formulation can we use to dissolve Obeticholic Acid (Catalog No.S7660) for mice in vivo study?

  • Answer:

    You can use the vehicle of: 1% wt/vol methyl-cellulose as indicated in this paper, http://www.sciencedirect.com/science/article/pii/S0925443911000883 "daily oral gavage with 5 mg/kg/day INT-747 (6-ethyl-chenodeoxycholic acid, Obeticholic acid, Intercept Pharmaceuticals Inc, New York, NY) or vehicle (1% wt/vol methyl-cellulose) from 3 days prior to induction of colitis"

Related FXR Products0

Tags: buy Obeticholic Acid | Obeticholic Acid supplier | purchase Obeticholic Acid | Obeticholic Acid cost | Obeticholic Acid manufacturer | order Obeticholic Acid | Obeticholic Acid distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID